Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α

Figure 3

AT III inhibits DSS-induced intestinal barrier impairment. (a, b) Western blots for occludin and ZO-1 proteins and quantification results. (c, d) Representative immunofluorescent images for occludin and quantification results. (e, f) Representative immunofluorescent images for ZO-1 and quantification results. Scale bar: 50 μm.

(a)

(b)

(c)

(d)

(e)

(f)